76 related articles for article (PubMed ID: 7678023)
1. Expression of 20 KD homologous restriction factor of complement on myocardial cells: an immunohistochemical study using acetone-fixed and paraffin-embedded tissues.
Tada T; Okada H; Okada N; Tateyama H; Eimoto T
J Histochem Cytochem; 1993 Jan; 41(1):119-22. PubMed ID: 7678023
[TBL] [Abstract][Full Text] [Related]
2. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo.
Nose M; Katoh M; Okada N; Kyogoku M; Okada H
Immunology; 1990 Jun; 70(2):145-9. PubMed ID: 1695609
[TBL] [Abstract][Full Text] [Related]
3. Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.
Tada T; Okada H; Okada N; Tateyama H; Suzuki H; Takahashi Y; Eimoto T
Virchows Arch; 1997 Apr; 430(4):327-32. PubMed ID: 9134044
[TBL] [Abstract][Full Text] [Related]
4. Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli. An immunofluorescence study.
Tamai H; Matsuo S; Fukatsu A; Nishikawa K; Sakamoto N; Yoshioka K; Okada N; Okada H
Clin Exp Immunol; 1991 May; 84(2):256-62. PubMed ID: 1709070
[TBL] [Abstract][Full Text] [Related]
5. Expression of HRF20, a regulatory molecule of complement activation, on peripheral blood mononuclear cells.
Hideshima T; Okada N; Okada H
Immunology; 1990 Mar; 69(3):396-401. PubMed ID: 1690178
[TBL] [Abstract][Full Text] [Related]
6. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.
Väkevä A; Laurila P; Meri S
Lab Invest; 1992 Nov; 67(5):608-16. PubMed ID: 1279272
[TBL] [Abstract][Full Text] [Related]
7. Characterization of homologous restriction factor (HRF20) in human skin and leucocytes.
Sayama K; Shiraishi S; Shirakata Y; Kobayashi Y; Okada N; Okada H; Miki Y
Clin Exp Immunol; 1990 Nov; 82(2):355-8. PubMed ID: 2242615
[TBL] [Abstract][Full Text] [Related]
8. Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection.
Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
Eur J Immunol; 1992 Jul; 22(7):1943-6. PubMed ID: 1378024
[TBL] [Abstract][Full Text] [Related]
9. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
Kuraya M; Yefenof E; Klein G; Klein E
Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.
Uesu T; Mizuno M; Inoue H; Tomoda J; Tsuji T
Lab Invest; 1995 May; 72(5):587-91. PubMed ID: 7538183
[TBL] [Abstract][Full Text] [Related]
11. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels.
Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW
Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288
[TBL] [Abstract][Full Text] [Related]
12. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions.
Seifert PS; Roth I; Schmiedt W; Oelert H; Okada N; Okada H; Bhakdi S
Atherosclerosis; 1992 Oct; 96(2-3):135-45. PubMed ID: 1281630
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of species-specific complement-mediated cytolysis in xenoendothelial cells transfected with GPI-anchored complement regulatory factor (DAF, HRF20) gene using retroviral vector: comparison between single (DAF or HRF20) and double (DAF and HRF20) transfected xenoendothelial cells.
Hayashi S; Isobe K; Emi N; Yokoyama I; Takagi H
Transplant Proc; 1994 Jun; 26(3):1243-4. PubMed ID: 7518119
[No Abstract] [Full Text] [Related]
14. Unique expression of HRF20 (CD59) in human nervous tissue.
Akatsu H; Yamada T; Okada N; Yamamoto T; Yamashina M; Okada H
Microbiol Immunol; 1997; 41(4):321-9. PubMed ID: 9159406
[TBL] [Abstract][Full Text] [Related]
15. Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues.
Meri S; Waldmann H; Lachmann PJ
Lab Invest; 1991 Nov; 65(5):532-7. PubMed ID: 1721667
[TBL] [Abstract][Full Text] [Related]
16. Rapid transformant selection by human complement using HRF20 (CD59) cDNA as a selection marker.
Takizawa H; Takahashi K; Murakami T; Okada N; Okada H
Eur J Immunol; 1993 Oct; 23(10):2714-6. PubMed ID: 7691615
[TBL] [Abstract][Full Text] [Related]
17. Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene.
Motoyama N; Okada N; Yamashina M; Okada H
Eur J Immunol; 1992 Oct; 22(10):2669-73. PubMed ID: 1382994
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.
Venneker GT; van den Hoogen FH; Boerbooms AM; Bos JD; Asghar SS
Lab Invest; 1994 Jun; 70(6):830-5. PubMed ID: 7516986
[TBL] [Abstract][Full Text] [Related]
19. The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining.
Sato Y; Mukai K; Watanabe S; Goto M; Shimosato Y
Am J Pathol; 1986 Dec; 125(3):431-5. PubMed ID: 2432790
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical demonstration of surface antigen of human lymphocytes with monoclonal antibody in acetone-fixed paraffin-embedded sections.
Tanaka M; Tanaka H; Ishikawa E
J Histochem Cytochem; 1984 Apr; 32(4):452-4. PubMed ID: 6368682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
